English | Español

American Academy Of Neurology
Sam Jackson | Apr 25, 2023

Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'
Sam Jackson | Apr 25, 2023

New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'

Press release submission | May 2, 2019

AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
Robert Hadley | May 16, 2017

Immunosuppressive drug cladribine may slow progression of MS

Ruth de Jauregui | May 7, 2017

Data from multiple sclerosis medication study shows promise
Robert Hadley | May 3, 2017

Clinical trial results offer hope for multiple sclerosis sufferers
Amanda Rupp | May 22, 2016

New ALS research announced at annual conference
Amanda Rupp | Apr 21, 2016

ALS Association announces new research fellowships

Trending
+ Pharmaceuticals
Patient Daily | Jun 2, 2025

PathAI collaborates with Northwestern Medicine on digital pathology advancements
+ Pharmaceuticals
Patient Daily | May 29, 2025

Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’
+ Regulatory
Patient Daily | May 30, 2025

Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation
+ Pharmaceuticals
Patient Daily | Jun 5, 2025

Exon 20 Group questions effectiveness of 340B drug program